NHI Relative Valuation
NHI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NHI is overvalued; if below, it's undervalued.
Historical Valuation
National Health Investors Inc (NHI) is now in the Fair zone, suggesting that its current forward PE ratio of 22.59 is considered Fairly compared with the five-year average of 20.51. The fair price of National Health Investors Inc (NHI) is between 66.92 to 83.17 according to relative valuation methord.
Relative Value
Fair Zone
66.92-83.17
Current Price：72.00
Fair
22.59
PE
1Y
3Y
5Y
Trailing
Forward
14.94
EV/EBITDA
National Health Investors Inc. (NHI) has a current EV/EBITDA of 14.94. The 5-year average EV/EBITDA is 15.22. The thresholds are as follows: Strongly Undervalued below 12.51, Undervalued between 12.51 and 13.86, Fairly Valued between 16.57 and 13.86, Overvalued between 16.57 and 17.93, and Strongly Overvalued above 17.93. The current Forward EV/EBITDA of 14.94 falls within the Historic Trend Line -Fairly Valued range.
20.64
EV/EBIT
National Health Investors Inc. (NHI) has a current EV/EBIT of 20.64. The 5-year average EV/EBIT is 21.46. The thresholds are as follows: Strongly Undervalued below 15.58, Undervalued between 15.58 and 18.52, Fairly Valued between 24.41 and 18.52, Overvalued between 24.41 and 27.35, and Strongly Overvalued above 27.35. The current Forward EV/EBIT of 20.64 falls within the Historic Trend Line -Fairly Valued range.
9.14
PS
National Health Investors Inc. (NHI) has a current PS of 9.14. The 5-year average PS is 8.79. The thresholds are as follows: Strongly Undervalued below 6.40, Undervalued between 6.40 and 7.60, Fairly Valued between 9.99 and 7.60, Overvalued between 9.99 and 11.19, and Strongly Overvalued above 11.19. The current Forward PS of 9.14 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
National Health Investors Inc. (NHI) has a current P/OCF of 0.00. The 5-year average P/OCF is 4.06. The thresholds are as follows: Strongly Undervalued below -6.28, Undervalued between -6.28 and -1.11, Fairly Valued between 9.23 and -1.11, Overvalued between 9.23 and 14.41, and Strongly Overvalued above 14.41. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
National Health Investors Inc. (NHI) has a current P/FCF of 0.00. The 5-year average P/FCF is 1.87. The thresholds are as follows: Strongly Undervalued below -6.07, Undervalued between -6.07 and -2.10, Fairly Valued between 5.84 and -2.10, Overvalued between 5.84 and 9.81, and Strongly Overvalued above 9.81. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
National Health Investors Inc (NHI) has a current Price-to-Book (P/B) ratio of 2.33. Compared to its 3-year average P/B ratio of 2.13 , the current P/B ratio is approximately 9.46% higher. Relative to its 5-year average P/B ratio of 2.03, the current P/B ratio is about 15.19% higher. National Health Investors Inc (NHI) has a Forward Free Cash Flow (FCF) yield of approximately 6.29%. Compared to its 3-year average FCF yield of 6.99%, the current FCF yield is approximately -10.11% lower. Relative to its 5-year average FCF yield of 7.32% , the current FCF yield is about -14.14% lower.
2.33
P/B
Median3y
2.13
Median5y
2.03
6.29
FCF Yield
Median3y
6.99
Median5y
7.32
Competitors Valuation Multiple
The average P/S ratio for NHI's competitors is 5.70, providing a benchmark for relative valuation. National Health Investors Inc Corp (NHI) exhibits a P/S ratio of 9.14, which is 60.27% above the industry average. Given its robust revenue growth of 9.55%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NHI decreased by 12.40% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 81.51M to 89.30M.
The secondary factor is the Margin Expansion, contributed 0.69%to the performance.
Overall, the performance of NHI in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is National Health Investors Inc (NHI) currently overvalued or undervalued?
What is National Health Investors Inc (NHI) fair value?
How does NHI's valuation metrics compare to the industry average?
What is the current P/B ratio for National Health Investors Inc (NHI) as of Aug 05 2025?
What is the current FCF Yield for National Health Investors Inc (NHI) as of Aug 05 2025?
What is the current Forward P/E ratio for National Health Investors Inc (NHI) as of Aug 05 2025?